布雷克萨诺龙治疗产后抑郁症的现实世界结果
Melanie Barrett1, Jennifer Hettema1, Constance Youngman1
1LifeStance Health, Scottsdale, Arizona, USA.
Women's health reports (New Rochelle, N.Y.)
|October 27, 2025
概括
布雷克萨诺在实际使用中显著降低了产后抑郁症 (PPD) 和焦虑症状,在12个月后持续作用. 这些真实世界的数据支持brexanolone.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 妇女健康 妇女健康
背景情况:
- 布雷克萨诺龙是一种FDA批准的输液,用于产后抑郁症 (PPD).
- 有限的现实世界数据存在于布雷克萨诺龙的有效性.
- 这项研究解决了布雷克萨诺龙在现实世界的有效性数据上的差距.
研究的目的:
- 描述接受布雷克萨诺隆治疗PPD的妇女的特征和治疗结果.
- 评估布雷克萨诺隆治疗的现实有效性和持续影响.
- 探索布雷克萨诺龙发现与祖兰诺龙的相关性.
主要方法:
- 来自150名接受布雷克萨诺龙治疗PPD的女性的现实世界临床数据.
- 治疗发生在住宅式门诊中心,随访时间长达12个月.
- 收集的数据包括抑郁和焦虑症状得分 (EPDS,PAS) 和反应/缓解率.
主要成果:
- 从治疗前到治疗后,抑郁症 (EPDS) 和焦虑症 (PAS) 症状显著减少.
- 在12个月的随访中持续减少症状.
- 治疗后的高响应率 (68.7%) 和缓解率 (46.7%),在12个月后增加 (73.4%和60.9%).
结论:
- 布雷克萨诺在治疗PPD和相关焦虑方面表现出显著的现实有效性.
- 在12个月内观察到持续的好处.
- 这些发现可能有助于使用祖拉诺,一种具有类似机制的口服药物.
相关概念视频
The Placebo Effect
6.8K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.8K
Depressive Disorders: MDD and Dysthymia
618
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
618
Depression: Overview
768
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
768
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Bipolar Disorder
612
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
612
Antidepressant Drugs: MAOIs and Other Agents
797
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
797

